Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record is now available, including the study design, eligibility criteria, outcomes, locations, publications, and individual participant data-sharing details.SummaryDifference100%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA sitewide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2, while the study page remains an error page.SummaryDifference1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual ClinicalTrials.gov study details and navigation. This change means the record is currently inaccessible and users cannot view study information or related resources from this page.SummaryDifference18%

- Check62 days agoChange DetectedThe footer revision tag updated from v3.6.6 to v3.7.0, signaling a newer page release. This change reflects a metadata or template update rather than alterations to the study content.SummaryDifference0.0%

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.